Shopping Cart 0
Cart Subtotal
USD 0

Sagent Pharmaceuticals Inc - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sagent Pharmaceuticals Inc (Sagent), formerly Sagent Holding Co, a subsidiary of Nichi-Iko Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and manufactures injectable products. The company offers products such as amikacin sulfate injection, USP, ampicillin and sulbactam for injection, ampicillin for injection, USP, azithromycin for injection, cefazolin for injection, USP, cefepime for injection, acetazolamide for injection, and adenosine injection. It also offers busulfan injection and pentobarbital sodium injection, USP. The company provides its products in injection and oral dosage forms. It markets its products across the US. Sagent is headquartered in Schaumburg, Illinois, the US.

Sagent Pharmaceuticals Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sagent Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Sagent Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Sagent Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Equity Offering 10

Sagent Pharma Completes Public Offering Of Shares For USD 75.3 Million 10

Acquisition 12

Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer 12

Sagent Pharma Acquires Omega Labs for USD85.3 Million 14

Sagent Pharmaceuticals Inc-Key Competitors 15

Sagent Pharmaceuticals Inc-Key Employees 16

Sagent Pharmaceuticals Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Joint Venture 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List Of Figure

List of Figures

Sagent Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sagent Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sagent Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Sagent Pharmaceuticals Inc, Medical Equipment, Key Facts 2

Sagent Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sagent Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sagent Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8

Sagent Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Sagent Pharma Completes Public Offering Of Shares For USD 75.3 Million 10

Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer 12

Sagent Pharma Acquires Omega Labs for USD85.3 Million 14

Sagent Pharmaceuticals Inc, Key Competitors 15

Sagent Pharmaceuticals Inc, Key Employees 16

Sagent Pharmaceuticals Inc, Subsidiaries 17

Sagent Pharmaceuticals Inc, Joint Venture 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sagent Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Sagent Pharmaceuticals Inc (Sagent), formerly Sagent Holding Co, a subsidiary of Nichi-Iko Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and manufactures injectable products. The company offers products such as amikacin sulfate injection, USP, ampicillin and sulbactam for injection, ampicillin for injection, USP, azithromycin for injection, cefazolin for injection, USP, cefepime for injection, acetazolamide for injection, and adenosine injection. It also offers busulfan injection and pentobarbital sodium injection, USP. The company provides its products in injection and oral dosage forms. It markets its products across the US. Sagent is headquartered in Schaumburg, Illinois, the US.

Sagent Pharmaceuticals Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sagent Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Sagent Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Sagent Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Equity Offering 10

Sagent Pharma Completes Public Offering Of Shares For USD 75.3 Million 10

Acquisition 12

Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer 12

Sagent Pharma Acquires Omega Labs for USD85.3 Million 14

Sagent Pharmaceuticals Inc-Key Competitors 15

Sagent Pharmaceuticals Inc-Key Employees 16

Sagent Pharmaceuticals Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Joint Venture 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List Of Figure

List of Figures

Sagent Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sagent Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sagent Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Sagent Pharmaceuticals Inc, Medical Equipment, Key Facts 2

Sagent Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sagent Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sagent Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8

Sagent Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Sagent Pharma Completes Public Offering Of Shares For USD 75.3 Million 10

Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer 12

Sagent Pharma Acquires Omega Labs for USD85.3 Million 14

Sagent Pharmaceuticals Inc, Key Competitors 15

Sagent Pharmaceuticals Inc, Key Employees 16

Sagent Pharmaceuticals Inc, Subsidiaries 17

Sagent Pharmaceuticals Inc, Joint Venture 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Sagent Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat